Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CAND2

CAND2

Basics

Aliases:
This biomarker is also known as:
  • cullin-associated and neddylation-dissociated 2 (putative),
  • cullin-associated NEDD8-dissociated protein 2,
  • cullin-associated and neddylation-dissociated protein 2,
  • TBP interacting protein,
  • p120 CAND2,
  • TBP-interacting protein of 120 kDa B,
  • Tp120b,
  • TIP120B,
  • TBP-interacting protein 120B,
  • KIAA0667,
  • Cullin-associated and neddylation-dissociated protein 2,
  • epididymis tissue protein Li 169,
  • Epididymis tissue protein Li 169,

View in BioMuta

Description…

cullin-associated and neddylation-dissociated 2 (putative)

Attributes

QA State: Under Review
Type: Gene
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html